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Nanomedicine has emerged during the past decades to
promise extraordinary breakthroughs in a wide range of
diagnostic and therapeutic endeavours. Understanding and
controlling the interfacial interactions of nanomaterials
with biological entities such as soluble and insoluble pro-
teins, biological membranes, and genetic materials are of
paramount importance towards their successful imple-
mentation in medical applications. This special ‘Nano-
medicine’ In Focus issue of Biointerphases illustrates the
way exquisite control of the unique physicochemical
properties of nanoscaled materials and advanced under-
standing of their bio-interfacial activity are rapidly trans-
lating into medically relevant applications as diverse as
regenerative medicine, molecular imaging, molecular
diagnosis, and targeted therapy.
One review article included in this special edition
focuses on stimuli responsive polymers and their applica-
tion in nanomedicine. The review by Palivan and
coworkers describes in particular the different types of
stimuli responsive materials and how their integration in
biomedical devices bears some exciting promises towards
advances in fields as diverse as drug delivery, biodiag-
nostics, cell culture and tissue engineering, or biosensing
[Stimuli-responsive polymers and their applications in
nanomedicine]. Along with this exciting review, an inno-
vative application of light responsive materials is presented
by Boyd, Hanley and collaborators (Fong et al.) [Alkyl-
ation of spiropyran moiety provides reversible photo-con-
trol over nanostructured soft materials for drug delivery].
In this work, photochromic spiropyran moieties are used to
achieve reversible photo-control over nanostructured liquid
crystalline systems, opening new horizons for on-demand
light-triggered drug delivery. A critical requirement
towards the integration of polymeric biomaterials in the
medical field is the understanding of their structure–activ-
ity relationship in contact with biological materials. Poly-
meric surfaces that resist non-specific adsorption of
proteins, bacteria, and higher organisms are of particularly
high interest in diverse applications ranging from drug
delivery to diagnostic devices and biomedical implants. A
study from Pidhatika and co-workers demonstrates that
coatings made of poly(2-methyl-2-oxazoline), a graft
copolymer with excellent non-fouling properties, are sig-
nificantly more stable than poly(ethylene glycol) ones
[Comparative stability studies of poly(2-methyl-2-oxazo-
line) and poly(ethylene glycol) brush coatings]. Such thin
films maintained their protein-repellent properties even
under aggressive conditions, and appear therefore as a
promising alternative to PEG in biomedical applications.
In a second review article in the special edition, Nisbet
and Williams provide an overview of nanostructured
supramolecular biomaterials that can be constructed by
non-covalent self-assembly of peptides [Self assembled
peptides: characterisation and in vivo response]. The article
focuses in particular on the structures and forces under-
pinning the formation of self-assembling scaffolds useful
for regenerative medicine applications. Such systems have
been widely explored in recent years to overcome the
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limitation of engineered scaffolds, which often fail to
appropriately recreate tissue analogues due to the intrinsic
complexity and hierarchical nature of biological tissue. An
exciting feature of peptide-based self-assembled scaffolds
is their compatibility with in vivo applications, as they can
be directly injected into diseased tissue to recruit native
cells, provide the required biological cues, and ultimately
promote regeneration. On the other range of the fabrication
spectrum, Brown et al. present an interesting innovative
approach to the fabrication of flexible tubular structures
designed for tissue engineering applications [Design and
fabrication of tubular scaffolds via direct writing in a melt
electrospinning mode]. By using non-conductive polymer
melts instead of polymer solutions, and using a finite ele-
ment model as a predictive design tool, the authors dem-
onstrate that the path and collection of electrospun fibers
becomes predictable, which results in cell-compatible
scaffolds with controllable mechanical properties and pat-
terns on the micron-scale.
Functional nanoparticles have become the poster child of
nanoscience in medicine, and diagnostic and therapeutic
nano-sized agents have already entered the clinical world,
with many more to come in the near future. Improved
control over nanoparticle synthesis is rapidly providing the
biomedical community with an ever-increasing number of
diagnostic and therapeutic materials with very potent
activities. Three research articles illustrate the therapeutic
and diagnostic potential of colloidal nanomaterials. In a
manuscript from the group of Tanja Weil, the design and
characterization of albumin-based micelles is reported
towards the development of robust nanocarriers of the
cytotoxic drug doxorubicin. An in vitro cytotoxicity five-
times higher than that of the free drug was observed, sug-
gesting the potential of such nanocarriers against cancer
[Nano-sized albumin-copolymer micelles for efficient
doxorubicin delivery]. Along with the potential to improve
the delivery of cytotoxic drugs, nanocarriers are being
actively advanced towards the development of safe and
efficient strategies to control gene expression and induce
therapeutic responses against a range of diseases. In an
article by Pei Li’s group, the ability of amphiphilic core–
shell nanoparticle to deliver gene in various mammalian cell
lines is demonstrated [Polyethylenimine-based amphiphilic
core–shell nanoparticles: study of gene delivery and intra-
cellular trafficking]. The well-defined branched polyethy-
lenimine shell facilitated the formation of plasmid DNA
complexes, making these core–shell carriers a potential
alternative to viral vectors. The diagnostic potential of
rationally designed nanoprobes is exemplified by a contri-
bution from Yukio Nagasaki’s group [Nano-sized albumin-
copolymer micelles for efficient doxorubicin delivery]. This
article describes the preparation of a hydroxylamine-con-
taining nanoparticle which emits an intense electron spin
resonance (ESR)-signal upon enzymatic oxidization and in
a pH-sensitive fashion, which could in turn enable ESR
imaging of inflammation in vivo. Despite these remarkable
progresses, the required understanding of the interactions
between colloidal nanomaterials and biological entities such
as cells, tissues and proteins remains limited; future pro-
gress in understanding the mechanistic aspects of nano-
particle performance in vitro and in vivo will be decisive for
successful translation to applications.
The biointerfacial properties of functional nanomaterials
are of critical importance in this regard, and mostly dictate
their fate in biological systems. A number of articles in the
Nanomedicine special edition cover the very critical issue
of nanoparticles and cell interactions, and demonstrate how
advanced biointerfaces can be used to control cellular
interactions. A study by Guangjun Nie’s group reports that
gold nanoparticles, although non-toxic, induce significant
change of gene expression, in this case up-regulation of
heme oxygenase-1, in a cell-specific manner, which draws
attention to the importance of intracellular molecular
mechanisms when deciphering the biological effects of
nanomaterials in cellular models [Deciphering an underly-
ing mechanism of differential cellular effects of nanopar-
ticles: an example of bach-1 dependent induction of ho-1
expression by gold nanorod]. Viruses, nature’s ultimate
nanocarriers, have evolved to be extremely efficient deliv-
ery vehicles for genetic materials. Understanding the
interactions between viruses and cells is therefore of tre-
mendous importance, not only to help fighting viral diseases
but also to assist scientists in developing better nanomedi-
cines. A manuscript from Nam-Joon Cho’s group reviews
the recent developments in the field of cell membrane
mimics and their uses to unravel the mechanisms of viral
membrane disruption [Model membrane platforms for
biomedicine: case study on antiviral drug development].
Further illustrating the importance of controlling cell
membranes and nanoparticles interactions, a manuscript
from Stellacci and coworkers reports that both ligand
arrangement and composition on gold nanoparticles play a
crucial role in their cellular internalization [Dynamic cel-
lular uptake of mixed-monolayer protected nanoparticles].
Using mixed self-assembled monolayers of thiolated
organic molecules, which spontaneously phase separately
into stripe-like domains, this study provides interesting
clues about how to overcome energy-mediated cellular
membrane transport processes. A feature of the special
edition describes a novel approach to controlling interac-
tions between liposomes and myoblast cells. The manu-
script from Brigitte Stadler’s group uses poly(dopamine)
(PDA), a eumelanin-like material deposited via the ‘‘self’’-
oxidative polymerization of dopamine, to coat liposomes
and control their interaction with cells [Myoblast cell
interaction with polydopamine coated liposomes]. In order
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to increase the biological specificity of nanocarriers such as
liposomes, molecular targeting approaches are being
actively sought. This topic is addressed in the special edi-
tion by a study from Alain Brisson’s group, which describes
an innovative platform to prepare antibody-presenting lip-
osomes [Development of a platform of antibody-presenting
liposomes]. Molecular targeting of liposomes is of very
high interest in molecular imaging and drug delivery, and
the proposed platform, based on the fusion of protein
between Annexin-A5 and the IgG binding ZZ repeat
derived from Staphylococcus aureus protein A, is an
interesting alternative to conventional covalent coupling
strategies. Such molecularly targeted approaches have been
advanced towards increased specificity to the target cells
and tissues, and thereby reduced systemic side effects while
improving diagnostics/therapeutics.
The lack of specificity of nanocarriers remains a sig-
nificant obstacle toward their clinical implementation, and
progresses have been slow in this area since the visionary
warning thirty years ago of Gregoriadis, who stated in the
Lancet that ‘‘there is little use for a carrier that although
highly selective in vitro, ends up in phagocytic cells or
cannot reach its destination in vivo’’ [1]. Innovative tar-
geting approaches combined with improved mechanistic
understanding, such as the one presented here, are steps in
the right direction towards fulfilling the tremendous
potential of nanomedicines.
Finally, two contributions by Bert Mu¨ller’s group
cover the development and application of advanced
characterization techniques to the field of nanomedicine:
(a) interrogation of structural details at the macro- to
nanoscale of human teeth by spatially resolved synchrotron
radiation-based small-angle X-ray scattering, shedding
light on the important, complex architecture of collagen
and anisotropic calcium phosphate crystallites of this hard
composite tissue; and (b) preparation of disposable, poly-
meric microcantilevers by micro-injection molding and
their validation in DNA hybridization experiments, which
may contribute in the future to the development of more
efficient medical diagnostics.
The Nanomedicine special edition covers a remarkable
range of important topics and provides exciting insights
into the very dynamic and fast growing nanomedicine field.
Nanomedicine is approaching the age of technological
maturity, and fundamental and applied research such as
that presented here will likely contribute not only to the
development of the knowledge and understanding required
to foster novel medical technologies, but also stimulate
new ideas and concepts.
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